HIV accessory proteins as therapeutic targets

Nature Medicine

Volumn 3, Issue 4, 1997, Pages 389-394

  Miller, Roger H ^a,b   Sarver, Nava ^a  

^a Natl Inst Allerg and Infect Dis   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; VIRUS VACCINE;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME;

AIDS VACCINES; DRUG DESIGN; GENE PRODUCTS, NEF; GENE PRODUCTS, VIF; GENE PRODUCTS, VPR; GENE PRODUCTS, VPU; HIV INFECTIONS; HIV-1; VACCINES, DNA; VIRAL REGULATORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031003928     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0497-389     Document Type: Review

References (13)

1. Pantaleo, G. & Fauci, A.S. Immunopathogenesis of HIV infection. Annu. Rev. Microbiol. 50, 825-854 (1996).
2. Richman, D.D. Clinical significance of drug resistance in human immunodeficiency virus. Clin. Infect. Dis. 21 (Suppl. 2), S166-169 (1995).
3. Kestler, H.W. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
4. Wyand, M.S., Manson, K.H., Garcia-Moll, M., Montefiori, D. & Desrosiers, R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70, 3724-3733 (1996).
5. Heinzinger, N.K. et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci USA 91, 7311-7315 (1994).
6. Yao, X.-J. et al. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69, 7032-7044 (1995).
7. Dubrovsky, L. et al. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. Mol. Med. 1, 217-230 (1995).
8. Jowett, J.B.M. et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+M phase of the cell cycle. J. Virol. 69, 6304-6313 (1995).
9. cdc2 activity. J. Virol. 69, 6705-6711 (1995).
10. cdc2-cyclin B. J. Virol. 69, 6859-6864 (1995).
11. DiMarzio, P., Choe, S., Ebright, M., Knoblauch, R. & Landau, N.R. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916 (1995).
12. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324-2331 (1996).
13. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122 (1995).